CatalystWireBeta

UK small-cap RNS · 26 May 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 14:53
    $50 million Share Buyback Programme
    Conduit Holdings, the ultimate parent company of Conduit Re, a Bermuda-based multi-line reinsurance business, today provides further details of the share buyback programme of up to $50 million which was announced on 13 May 2026 (the "Buyback Programme").
    Capital return −2.1% on the day
  2. 13:30
    Holding(s) in Company Holding
  3. 13:04
    Holding(s) in Company Holding
  4. 12:46
    Half-year Results Results
    Loss after tax rose to £1.04m from £0.18m as administrative costs reached £0.91m. The extract shows no revenue or cash figure, so funding runway is unclear until P1 financing closes.
    Project milestones outlook positive −1.6% on the day
    Moved: Orom-Cross DFS and JORC update: DFS optimisation advanced; funding talks ongoing → DFS update pending; P1 financing in due diligence · Lyan and Beehive exploration assays: Maiden Beehive JORC issued; Orom-Cross at 64.3 Mt → Maiden Beehive JORC issued; deep holes ended in graphite
  5. 08:30
    Revised PFS for Optimised Dokwe Gold Project
    Optimised Dokwe Gold Project PFS Yields Excellent Metrics
    Project milestones outlook positive +10.8% on the day
    Moved: Dokwe RC drilling campaign: Funded by Zenit sale; diamond drilling next → Revised PFS completed; DFS in progress
  6. 07:09
    1st Quarter Results Results
    Q1 revenue rose 9.3% and operating cash flow reached US$10.2m, but EBITDA was flat at US$11.3m with margin down to 34.4%, and net debt rose to US$576.2m.
    Moved: Delayed SSN and SUN coupon payment: Coupons still unpaid; licences applied for → Coupons unpaid; licences applied for · Chinarevskoye drilling and workovers: Review underway; workovers managing decline → Review underway; no timetable · Ural O&G third-party processing: Feedstock still ramping in Q1 2026 → Feedstock still ramping in Q1 2026
  7. 07:01
    Commencement of Share Buyback Programme
    Up to £50m of surplus capital is returned by buying back and cancelling shares, superseding the £20m programme begun in October 2025. Brokers trade independently, and completion is expected by 24 November 2026.
    Capital return £50.0m · 6% of mcapfirst in 7 months +5.8% on the day
    Moved: £20m share buyback programme: Enlarged to up to £50m → £50m programme commenced via two brokers
  8. 07:00
    Refinancing, Launch of SBB and Acquisition
    Adds a Sydney single-site practice for A$8.2m (c.£4m) and signs a second at A$3.2m (c.£1.7m), continuing the Australia roll-out of c.£50m a year; both are small bolt-ons.
    New CEO / reset £4.0m · 0% of mcapfirst since Oct 2023 +5.8% on the day
    Moved: £20m share buyback programme: Under way; adds to higher net borrowings → Enlarged to up to £50m · Australia acquisition programme: Two completed since period end, one exchanged → One completed, one signed · CEO succession: Search to be initiated; Fairman stays until successor → Search at early stages
  9. 07:00
    Trading Update and Issuance of Sancus Bond Trading update
    Revenue is up 44% but slower deployment, longer loan durations and higher cash carry costs leave first-half profit below management expectations. This cuts against the March confidence in run-rate profitability in 2026.
    Balance-sheet stress / refinancing £0.5m · 5% of mcapbelow expectationsoutlook mixed, lowered3 business updates in 3 months – usually less than 1 −8.0% on the day
    Moved: Funding facility capacity and maturity: Pollen Street £300m to 2031; £150m drawn → Cash carry costs weigh; shareholder bond adds working capital
  10. 07:00
    WHM Strategic Production Sharing Agreement
    Kazera Global plc (AIM: KZG), the AIM-quoted investment company, is pleased to announce that its wholly owned subsidiary, Whale Head Minerals (Pty) Ltd ("WHM"), has entered into a binding Production Sharing Agreement ("PSA") with South African mineral …
    Project milestones outlook positivenext step +12.2% on the day
    Moved: HMS and diamond capacity expansion: Diamond expansion scaled back; HMS partner talks → REMI production sharing partner signed · Board reset and new CEO: Reset continues; another non-executive leaves → HMS operating partner secured · 2A Mining Right approval: Final stages; local stakeholder engaged → Grant anticipated; CPR due late June
  11. 07:00
    Corporate update
    Celsius Resources Limited ("Celsius" or the "Company") (+ASX, AIM: CLA) wishes to provide an update in relation to the following:
    Disposal of a part (break-up) outlook mixed +0.0% on the day
    Moved: MCB copper-gold project development: Funding phase two; loan assigned to Kiri → Loan assigned to Kiri; Celsius contesting offtake · Sodor 60% MCB interest transfer: Interim orders denied 5 May; arbitration continuing → Broader arbitration; Sodor controls MMCI board · Sale of Opuwo Project: Sale process continuing → Binding SPA expected by end June 2026
  12. 07:00
    Final Results Results
    The Board only says 2026 targets are 'on track'; no new number is given. The 25% growth guided in January is not raised. Q1 constant-currency growth of 15% means the rest of the year must accelerate.
    Upgrade / downgrade cycle £38.9m · 23% of mcapin lineoutlook positive −9.3% on the day
    Moved: FY 2026 revenue growth guidance: 25% FY 2026 revenue growth guided → Reaffirmed as on track; Q1 up 15% constant currency
  13. 07:00
    Strategic Update May 2026
    After the terminated £15m parent raise, funding is to shift to subsidiary-level spin-outs after catalysts, avoiding parent dilution. But nothing is committed, and the Board is only 'evaluating' options.
    Dilutive fundraise £0.5m · 26% of mcapoutlook positivefirst in 10 months +10.3% on the day
    Moved: Lab-grown leather commercial launch: A4 sheets tanned; samples to fashion house → Tanned skin done; Paris auction set · Alternative fundraising options: Discussions ongoing with other parties → Evaluating subsidiary-level spin-out financing · Kerato liquid cornea veterinary trial: Grant-backed trial funded; data from early 2026 → Phase 1 vet trials underway; midpoint reached
  14. 07:00
    Final Results Results
    Net loss of £7.03m after impairing Biscathorpe, North Kelsey and Sark, with revenue down to £2.49m from £3.93m and gross profit down to £0.69m from £1.97m. The company remains debt free.
    Project milestones £2.5m · 104% of mcapoutlook positivefirst in 7 months −15.8% on the day
    Moved: Crossroads well, Oklahoma: Spud delayed again; rig under repair → Drilled in May 2026; awaiting testing · Shareholder board challenge at AGM: Requisitioned resolutions to go to June AGM → AGM date fixed; notice issued

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note